The Worldwide Continuous Subcutaneous Insulin Infusion Industry is Expected to Reach $4.25 Billion by 2027: Rising Awareness of Advanced Insulin Delivery Devices Drives Growth
February 02, 2023 13:03 ET
|
Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Global Continuous Subcutaneous Insulin Infusion Market (2022-2027) by Products, Patient Type, End-Uses, and Geography, Competitive Analysis and the...
Type 2 Diabetes Treatment Global Market Outlook Report 2022-2027: Combination of Next Generation Treatments, High Unmet Needs, & Premium Pricing to Drive Growth
January 25, 2023 04:58 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes Treatment: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market has been...
Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment
January 09, 2023 08:30 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Global Diabetes Insulin Delivery Pen Market 2022: A $22.17 Billion Market by 2028 - The Most Up-to-Date Industry Data on the Actual Market Situation and Future Outlook
December 21, 2022 04:13 ET
|
Research and Markets
Dublin, Dec. 21, 2022 (GLOBE NEWSWIRE) -- The "Global Diabetes Insulin Delivery Pen Market 2022: Insights, Trends, Competition, Growth Opportunities, Market Size, Market Share Data, Analysis Outlook...
Global Insulin Pumps Pipeline Analysis Report 2022: Breakdown by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
December 15, 2022 05:48 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report...
Global Insulin Pen Market Report to 2027 - Featuring B. Braun Melsungen, Eli Lilly and Company, BD and Novo Nordisk Among Others
December 07, 2022 07:00 ET
|
Research and Markets
Dublin, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Insulin Pen Market, Users, Global Forecast 2023-2027, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
The Worldwide Smart Insulin Pens & Pumps Industry is Expected to Reach $478 Million by 2027: Increasing Awareness of Diabetic Management Tools is Driving Growth
November 25, 2022 06:48 ET
|
Research and Markets
Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Smart Insulin Pens & Pumps Market (2022-2027) by Products, End-Users, and Geography, Competitive Analysis and the Impact of Covid-19 with...
Pen Needles Market Size to Gain $2.2 Billion by 2025 with CAGR of 4.6%, Exclusive Report by The Insight Partners
November 21, 2022 07:01 ET
|
The Insight Partners
New York, Nov. 21, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners new research study on "Pen Needles Market Size, Share, Growth, Trends and Forecast to 2025 – Global Analysis – by Type,...
Biosimilar Growth Hormones Global Market Report 2022: Recombinant DNA Technology Presents Lucrative Opportunities
November 10, 2022 07:43 ET
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Growth Hormones Global Market Report 2022: By Route, By Application, By Distribution" report has been added to ResearchAndMarkets.com's...
Global Antidiabetics Market Anticipated to Generate a Revenue of $148.3 Billion and Grow at a CAGR of 11.1% during the forecast period 2020-2027 | Analysis by Research Dive
October 31, 2022 09:01 ET
|
Research Dive
New York, USA, Oct. 31, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global antidiabetics market is envisioned to garner a revenue of $148.3 billion by 2027,...